Accesswire · 17 Aug 2026positive
DataMeds AI, Inc. (formerly Wellgistics Health) reported Q2 2026 revenues of $1.779 million, up 14% and ahead of management projections, and provided a business update that covered its July 2026 corporate name and ticker change to MEDS, $6.5 million in new June 2026 funding, a pending four-party consolidation of intellectual property tied to the "Health Lives Here" consumer app launch with NFL Alumni Health, a 1:50 reverse split, 49% of shares under lock-up agreements, a Meme Coin token distribution, the KareRx joint venture's EBV addition, and the termination of the Neuritek acquisition.
Why it matters — MEDS watchers would care because this update details the company's turnaround progress, funding, restructuring measures, and near-term product launch plans that define its outlook following the corporate rebrand and NASDAQ listing changes.
Accesswire · 14 Aug 2026neutral
DataMeds AI's board of directors set September 9, 2026 as the payment date for the previously announced distribution of Dream Bowl Meme Coin I tokens to common stockholders and eligible equity security holders as of the record date of August 7, 2026.
Why it matters — This announcement confirms the timing of a non-cash distribution to shareholders that will result in Meds stakeholders receiving 50 Dream Bowl Tokens for each share of common stock held.
Accesswire · 12 Aug 2026positive
DataMeds AI announced that its subsidiary Corexa Health's pharmacy division, Corexa Pharmacy, reached milestones including the availability of GLP-1 agonist drugs, integration of online store CorexaRx.com into the Health Lives Here app, and new availability of medical foods Forzet and Galectovid plus supplement Tollovid. July 2026 revenue stabilized above $600,000 as the pharmacy prepares to expand with the Health Lives Here app launch alongside NFL Alumni Health.
Why it matters — A MEDS watcher would care because Corexa Pharmacy is positioned as the centerpiece of company growth for the second half of 2026, and the update indicates stabilizing revenue and expansion catalysts tied to its Health IT and AI platforms.
Accesswire · 10 Aug 2026neutral
DataMeds AI, Inc. (NASDAQ:MEDS) announced that it has completed name changes of its pharmacy and pharmacy-hub subsidiaries, now known as Corexa Pharmacy, LLC and Corexa Tech & Hub, LLC, respectively. Both subsidiaries now operate under the Company's newly renamed pharmacy-focused division, Corexa Health, LLC.
Why it matters — The reorganization signals how DataMeds AI is structuring its pharmacy operations under a unified Corexa Health division, which may matter to investors tracking the Company's corporate framework.
Accesswire · 6 Aug 2026neutral
DataMeds AI, Inc. (NASDAQ:MEDS) reiterated the August 7, 2026 record date for its 50:1 Dream Bowl Meme Coin token to common shares dividend ratio, and noted the official platform for the tokens is Biconomy.
Why it matters — MEDS watchers would care because the announcement provides a definitive record date and reiterates the terms for the company's token-to-share dividend.
